Health Catalyst (NASDAQ:HCAT) Shares Cross Above 200-Day Moving Average - Here's What Happened

Key Points

• Health Catalyst shares rose 14.6%, trading as high as $1.835 and closing around $1.80, above the 200-day moving average of $1.73.
• Analyst sentiment remains cautious: the stock has a consensus “Hold” rating, with two Buys, five Holds and one Sell, and an average price target of $2.01.
• The company modestly exceeded quarterly expectations, reporting $70.49 million in revenue and $0.04 earnings per share versus estimates of $69.09 million and $0.03, respectively; CEO Simeon Kohl also purchased 59,000 shares.

Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report)'s stock price passed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $1.73 and traded as high as $1.8350. Health Catalyst shares last traded at $1.80, with a volume of 695,473 shares changing hands.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. Weiss Ratings reissued a "sell (d-)" rating on shares of Health Catalyst in a research report on Monday. Wells Fargo & Company reduced their price target on shares of Health Catalyst from $1.75 to $1.50 and set an "equal weight" rating for the company in a research note on Thursday, August 13th. Citigroup lowered their price objective on shares of Health Catalyst from $2.50 to $2.00 and set a "neutral" rating on the stock in a research note on Tuesday, August 11th. Finally, Canaccord Genuity Group downgraded Health Catalyst from a "buy" rating to a "hold" rating and reduced their target price for the company from $3.00 to $1.80 in a report on Thursday, August 20th. Two analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $2.01.

Health Catalyst Stock Up 14.6%

The company has a market cap of $135.47 million, a price-to-earnings ratio of -0.49 and a beta of 1.54. The company has a current ratio of 2.70, a quick ratio of 2.70 and a debt-to-equity ratio of 1.51. The business has a fifty day moving average price of $1.71 and a two-hundred day moving average price of $1.73.

Health Catalyst (NASDAQ:HCAT - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.04 EPS for the quarter, topping the consensus estimate of $0.03 by $0.01. Health Catalyst had a negative net margin of 90.61% and a negative return on equity of 1.83%. The business had revenue of $70.49 million during the quarter, compared to analysts' expectations of $69.09 million. On average, equities analysts predict that Health Catalyst, Inc. will post -0.18 earnings per share for the current year.

Insider Transactions at Health Catalyst

In other news, CEO Simeon Kohl bought 59,000 shares of the stock in a transaction on Monday, September 14th. The shares were purchased at an average price of $1.79 per share, for a total transaction of $105,610.00. Following the completion of the purchase, the chief executive officer directly owned 2,856,385 shares of the company's stock, valued at $5,112,929.15. This trade represents a 2.11% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 19.40% of the company's stock.

Institutional Trading of Health Catalyst

Large investors have recently added to or reduced their stakes in the business. Visionary Wealth Advisors acquired a new stake in shares of Health Catalyst in the second quarter worth $27,000. AXQ Capital LP acquired a new position in Health Catalyst in the 2nd quarter valued at $38,000. Deutsche Bank AG acquired a new position in Health Catalyst in the 2nd quarter valued at $43,000. Perigon Wealth Management LLC acquired a new position in Health Catalyst during the 2nd quarter worth $77,000. Finally, EP Wealth Advisors LLC acquired a new position in Health Catalyst during the 2nd quarter worth $99,000. 85.00% of the stock is owned by institutional investors.

About Health Catalyst

Health Catalyst, Inc is a healthcare technology company that provides data and analytics solutions to help healthcare organizations improve clinical outcomes, operational efficiency and financial performance. Its customers include hospitals, health systems, medical groups and other healthcare organizations seeking to integrate and analyze data from across their operations.

The company's offerings are built around its Health Catalyst Data Operating System, a cloud-based platform designed to combine information from electronic health records, financial systems and other sources.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.